Chemokines and disease
The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
We examine here several diseases that are associated with inappropriate activation of the chemokine network. Detailed comment has been restricted to pathological states for which there are compelling data either from clinical observations or animal models. These include cardiovascular disease, allergic inflammatory disease, transplantation, neuroinflammation, cancer and HIV-associated disease. Discussion focuses on therapeutic directions in which the rapidly evolving chemokine field appears to be headed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, among the 30 enriched terms, two GO-terms are T-cell chemotaxis and cell–cell adhesion which play a critical role in the immune system (Springer, 1990; Gerard and Rollins, 2001; Bach et al., 2007).”
From Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed (2019) · cites this paper as Gerard and Rollins, 2001
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Self-citationQin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Self-citationBoring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Research works printed but not linked: 3
- Wedderburn, L. R., Robinson, N., Patel, A., Varsani, H. & Woo, P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 43, 765–774 (2000). · doi:10.1002/1529-0131(200004)43:4<765::aid-anr7>3.0.co;2-b
- Bashford, E. F. in Scientific Reports on the Investigations of the ICRF (eds Bashford, E. F., Murray, J. A. & Cramer, W.) (ICRF, London, 1905).
- Russell, B. R. G. The nature of resistance to the inoculation of cancer. Sci. Rep. ICRF 3, 341–358 (1908).
Cited by
Items 301–400 of 1,001
Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.
Chen, X., Beutler, J. A., McCloud, T. G., Loehfelm, A., Yang, L., Dong, H., Chertov, O., Salcedo, R., Oppenheim, J. J., & Howard, O. M. Z. (2003) · PubMed · Cited by 99
CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation
Chung, D. R., Chitnis, T., Panzo, R. J., Kasper, D. L., Sayegh, M. H., & Tzianabos, A. O. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020028 · Cited by 91
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Swaminathan, G. J., Holloway, D. E., Colvin, R. A., Campanella, G. K., Papageorgiou, A. C., Luster, A. D., & Acharya, K. R. (2003) · Structure · doi:10.1016/s0969-2126(03)00070-4 · Cited by 98
Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors
Szpakowska, M., Fiévez, V., Arumugan, K., van Nuland, N. A. J., Schmit, J., & Chevigné, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.008 · Cited by 98
Inflammation and Type 2 Diabetes: Results from KORA Augsburg
Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., et al. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858252 · Cited by 97
“Chemokines represent a family of small molecular weight proteins which control leukocyte trafficking and activation and act as key mediators of inflammation and other patho-physiological states [37, 38].”
BackgroundTakahashi, M., Galligan, C., Tessarollo, L., & Yoshimura, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802812 · Cited by 86
Bacterial Clearance in Septic Mice Is Modulated by MCP-1/CCL2 and Nitric Oxide
Gomes, R. N., Teixeira-Cunha, M. G. A., Figueiredo, R. T., de Almeida, P. E., Alves, S. C., Bozza, P. T., Bozza, F. A., Bozza, M. T., Zimmerman, G. A., & Castro-Faria-Neto, H. C. (2012) · Shock · doi:10.1097/shk.0b013e31827802b5 · Cited by 97
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation
Frommhold, D., Ludwig, A., Bixel, M. G., Zarbock, A., Babushkina, I., Weissinger, M., Cauwenberghs, S., Ellies, L. G., Marth, J. D., Beck-Sickinger, A. G., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070846 · Cited by 81
CCR6 has a non‐redundant role in the development of inflammatory bowel disease
Varona, R., Cadenas, V., Flores, J., Martínez‐A., C., & Márquez, G. (2003) · European Journal of Immunology · doi:10.1002/eji.200324347 · Cited by 88
Viral chemokine-binding proteins
Seet, B. T., & McFadden, G. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.24 · Cited by 97
Targeting inflammation to reduce recurrent stroke
Zietz, A., Gorey, S., Kelly, P. J., Mira, K., & McCabe, J. J. (2023) · International Journal of Stroke · doi:10.1177/17474930231207777 · Cited by 96
Pan, H., Luo, C., Li, R., Qiao, A., Zhang, L., Mines, M., Nyanda, A. M., Zhang, J., & Fan, G.-H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704934200 · Cited by 92
IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB
Burke, S. J., Stadler, K., Lu, D., Gleason, E. L., Han, A., Donohoe, D. R., Rogers, R. C., Hermann, G. E., Karlstad, M. D., & Collier, J. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2015 · Cited by 96
Absence of CCR8 Does Not Impair the Response to Ovalbumin-Induced Allergic Airway Disease
Goya, I., Villares, R., Zaballos, A., Gutiérrez, J., Kremer, L., Gonzalo, J.-A., Varona, R., Carramolino, L., Serrano, A., Pallarés, P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2138 · Cited by 85
Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection
Yun, J. J., Whiting, D. J., Fischbein, M. P., Banerji, A., Irie, Y., Stein, D., Fishbein, M. C., Proudfoot, A. E. I., Laks, H., Berliner, J. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000112595.65972.8a · Cited by 96
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats
Barsante, M. M., Cunha, T. M., Allegretti, M., Cattani, F., Policani, F., Bizzarri, C., Tafuri, W. L., Poole, S., Cunha, F. Q., Bertini, R., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707462 · Cited by 95
Relationships between glycosaminoglycan and receptor binding sites in chemokines—the CXCL12 example
Laguri, C., Arenzana‐Seisdedos, F., & Lortat‐Jacob, H. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.01.047 · Cited by 95
Inhibition of Cytokine Production by Hymenialdisine Derivatives
Sharma, V., Lansdell, T. A., Jin, G., & Tepe, J. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040013d · Cited by 95
Vyas, K., Chaudhuri, S., Leaman, D. W., Komar, A. A., Musiyenko, A., Barik, S., & Mazumder, B. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00824-08 · Cited by 82
Saito, Y., Hasegawa, M., Fujimoto, M., Matsushita, T., Horikawa, M., Takenaka, M., Ogawa, F., Sugama, J., Steeber, D. A., Sato, S., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701258 · Cited by 94
Rankine, E. L., Hughes, P. M., Botham, M. S., Perry, V. H., & Felton, L. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04891.x · Cited by 85
DeMarco, S. J., Henze, H., Lederer, A., Moehle, K., Mukherjee, R., Romagnoli, B., Robinson, J. A., Brianza, F., Gombert, F. O., Lociuro, S., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.003 · Cited by 94
Vivès, R. R., Sadir, R., Imberty, A., Rencurosi, A., & Lortat‐Jacob, H. (2002) · Biochemistry · doi:10.1021/bi026459i · Cited by 94
Li, L., & Jiang, B.-E. (2015) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563214545117 · Cited by 83
Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance
Finucane, O. M., Reynolds, C. M., McGillicuddy, F. C., & Roche, H. M. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000730 · Cited by 94
Post-translational control of chemokines: a role for decoy receptors?
Comerford, I., & Nibbs, R. J. B. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.08.018 · Cited by 94
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Mehraj, U., Mushtaq, U., Mir, M. A., Saleem, A., Macha, M. A., Lone, M. N., Hamid, A., Zargar, M. A., Ahmad, S. M., & Wani, N. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.008 · Cited by 93
Sheehan, J. J., Zhou, C., Gravanis, I., Rogove, A. D., Wu, Y., Bogenhagen, D. F., & Tsirka, S. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4987-06.2007 · Cited by 93
Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3
Govaerts, C., Bondue, A., Springael, J., Olivella, M., Deupí, X., Poul, E. L., Wodak, S. J., Parmentier, M., Pardo, L., & Blanpain, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205685200 · Cited by 94
Monocyte chemoattractant protein-1 and atherosclerosis: Is there room for an additional biomarker?
Coll, B., Alonso‐Villaverde, C., & Joven, J. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.019 · Cited by 92
Blockade of Inflammatory Responses by a Small-Molecule Inhibitor of the Rac Activator DOCK2
Nishikimi, A., Uruno, T., Duan, X., Cao, Q., Okamura, Y., Saitoh, T., Saito, N., Sakaoka, S., Du, Y., Suenaga, A., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.03.008 · Cited by 92
Translation Control: A Multifaceted Regulator of Inflammatory Response
Mazumder, B., Li, X., & Barik, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903778 · Cited by 80
Yoshida, S., Arakawa, F., Higuchi, F., Ishibashi, Y., Goto, M., Sugita, Y., Nomura, Y., Niino, D., Shimizu, K., Aoki, R., et al. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.623137 · Cited by 93
Ren, H., Yu, D., Ge, B., Cook, B., Xu, Z., & Zhang, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004509 · Cited by 91
Vongsa, R. A., Zimmerman, N. P., & Dwinell, M. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805289200 · Cited by 91
Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis
Mukhamedshina, Y. O., Akhmetzyanova, E. R., Martynova, E. V., Khaiboullina, S. F., Galieva, L. R., & Rizvanov, A. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00581 · Cited by 90
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes
González-Quesada, C. J., & Frangogiannis, N. G. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0021-y · Cited by 90
Knockout of ccr2 alleviates photoreceptor cell death in a model of retinitis pigmentosa
Guo, C., Otani, A., Oishi, A., Kojima, H., Makiyama, Y., Nakagawa, S., & Yoshimura, N. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.08.013 · Cited by 80
Morphine modulates chemokine gene regulation in normal human astrocytes
Mahajan, S. D., SCHWARTZ, S., Aalinkeel, R., Chawda, R. P., Sykes, D., & Nair, M. G. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.004 · Cited by 90
PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia
Struyf, S., Schutyser, E., Gouwy, M., Gijsbers, K., Proost, P., Benoît, Y., Opdenakker, G., Damme, J. V., & Laureys, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63564-x · Cited by 90
Murphy, C. A., Hoek, R. M., Wiekowski, M. T., Lira, S. A., & Sedgwick, J. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7054 · Cited by 82
Choe, C.-U., Lardong, K., Gelderblom, M., Ludewig, P., Leypoldt, F., Koch-Nolte, F., Gerloff, C., & Magnus, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019046 · Cited by 79
Vukkadapu, S. S., Belli, J. M., Ishii, K., Jegga, A. G., Hutton, J. J., Aronow, B. J., & Katz, J. D. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00173.2004 · Cited by 73
Usui, M., Egashira, K., Ohtani, K., Kataoka, C., Ishibashi, M., Hiasa, K., Katoh, M., Zhao, Q. D., Kitamoto, S., & Takeshita, A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0094fje · Cited by 89
Nelson, T. E., & Gruol, D. L. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.009 · Cited by 88
Wang, Z., Liu, B., Wang, P., Dong, X., Fernandez-Hernando, C., Li, Z., Hla, T., Li, Z., Claffey, K., Smith, J. D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33139 · Cited by 77
Identification of the Cytoplasmic Domains of CXCR4 Involved in Jak2 and STAT3 Phosphorylation
Ahr, B., Denizot, M., Robert-Hebmann, V., Brelot, A., & Biard-Piechaczyk, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408481200 · Cited by 78
Involvement of stromal proteoglycans in tumour progression
Wegrowski, Y., & Maquart, F. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.10.005 · Cited by 88
Reale, M., Kamal, M. A., Patruno, A., Costantini, E., D’Angelo, C., Pesce, M., & Greig, N. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104973 · Cited by 86
CXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz, G. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00226.x · Cited by 80
CCL5-CCR5-mediated Apoptosis in T Cells
Murooka, T. T., Wong, M., Rahbar, R., Majchrzak-Kita, B., Proudfoot, A. E. I., & Fish, E. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603912200 · Cited by 86
Maggio, E. M., van den Berg, A., Visser, L., Diepstra, A., Kluiver, J. L., Emmens, R., & Poppema, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10399 · Cited by 86
Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms
Kanakiriya, S. K. R., Croatt, A. J., Haggard, J. J., Ingelfinger, J. R., Tang, S.-S., Alam, J., & Nath, K. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00298.2002 · Cited by 83
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis
Kang, J., Postigo-Fernandez, J., Kim, K., Zhu, C., Yu, J., Meroni, M., Mayfield, B., Bartolomé, A., Dapito, D. H., Ferrante, A. W., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165369 · Cited by 78
Lipid bodies in innate immune response to bacterial and parasite infections
D’Ávila, H., Maya‐Monteiro, C. M., & Bozza, P. T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.01.035 · Cited by 85
Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice
Shimizu, S., Nakashima, H., Masutani, K., Inoue, Y., Miyake, K., Akahoshi, M., Tanaka, Y., Egashira, K., HIRAKATA, H., Otsuka, T., et al. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh277 · Cited by 85
Crisman, J. M., Zhang, B., Norman, L. P., & Bond, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4510 · Cited by 78
Malik, I. A., Moriconi, F., Sheikh, N., Naz, N., Khan, S., Dudás, J., Mansuroglu, T., Hess, C. F., Rave‐Fränk, M., Christiansen, H., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090505 · Cited by 84
Lu, P., Nakamoto, Y., Nemoto‐Sasaki, Y., Fujii, C., Wang, H., Hashii, M., Ohmoto, Y., Kaneko, S., KOBAYASHI, K. P., & Mukaida, N. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63921-1 · Cited by 84
Ramesh, G., Benge, S., Pahar, B., & Philipp, M. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-72 · Cited by 79
Akodad, M., Fauconnier, J., Sicard, P., Huet, F., Blandel, F., Bourret, A., Barbara, P. D. S., Aguilhon, S., Gall, M. L., Hugon, G., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.126 · Cited by 84
Saadoun, D., Bièche, I., Maisonobe, T., Asselah, T., Laurendeau, I., Piette, J. C., Vidaud, M., & Cacoub, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21270 · Cited by 83
Patsouris, D., Neels, J. G., Fan, W., Li, P.-P., Nguyen, M. T. A., & Olefsky, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041665 · Cited by 84
T‐Lymphocytes Expressing CC Chemokine Receptor‐5 Are Increased in Frail Older Adults
De Fanis, U., Wang, G. C., Fedarko, N. S., Walston, J. D., Casolaro, V., & Leng, S. X. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01673.x · Cited by 81
Law, A. H. Y., Lee, D. C. W., Cheung, B. K. W., Yim, H. C. H., & Lau, A. S. Y. (2006) · Journal of Virology · doi:10.1128/jvi.02336-05 · Cited by 83
Boström, S., Giusti, P., Arama, C., Persson, J., Dara, V., Traoré, B., Dolo, A., Doumbo, O. K., & Troye‐Blomberg, M. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-109 · Cited by 83
Matsui, M., Weaver, J., Proudfoot, A. E. I., Wujek, J. R., Wei, T., Richer, E., Trapp, B. D., Rao, A., & Ransohoff, R. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00121-2 · Cited by 83
The role of CC chemokine receptor 5 in antiviral immunity
Nansen, A., Christensen, J. P., Andreasen, S. Ø., Bartholdy, C., Christensen, J. E., & Thomsen, A. R. (2002) · Blood · doi:10.1182/blood.v99.4.1237 · Cited by 83
Reinhart, T. A., Fallert, B. A., Pfeifer, M. E., Sanghavi, S., Capuano, S., Rajakumar, P. A., Murphey‐Corb, M., Day, R., Fuller, C. L., & Schaefer, T. M. (2002) · Blood · doi:10.1182/blood.v99.9.3119 · Cited by 83
Chen, X., Geller, E. B., Rogers, T. J., & Adler, M. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.010 · Cited by 82
The role of regulatory T cells in malignant glioma.
Sonabend, A. M., Rolle, C. E., & Lesniak, M. S. (2008) · PubMed · Cited by 82
Oonakahara, K.-I., Matsuyama, W., Higashimoto, I., Kawabata, M., Arimura, K., & Osame, M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0340oc · Cited by 82
RetractedMini-review series: focus on chemokines
Comerford, I., & McColl, S. R. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.164 · Cited by 81
Molecular Dynamics Simulations on SDF-1α: Binding with CXCR4 Receptor
Huang, X., Shen, J., Cui, M., Shen, L., Luo, X., Ling, K., Pei, G., Jiang, H., & Chen, K. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74840-1 · Cited by 82
Maxion, H. K., & Kelly, K. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1538-1546.2002 · Cited by 81
Liou, J.-T., Yuan, H.-B., Mao, C.-C., Lai, Y.-S., & Day, Y. (2012) · Pain · doi:10.1016/j.pain.2012.03.008 · Cited by 80
Rao, Y. K., Fang, S., & Tzeng, Y. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.912 · Cited by 80
Deciphering sex differences in the immune system and depression
Rainville, J. R., Tsyglakova, M., & Hodes, G. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.004 · Cited by 72
CCR5-Δ32 mutation is strongly associated with primary sclerosing cholangitis
Eri, R. D., Jonsson, J. R., Pandeya, N., Purdie, D. M., Clouston, A. D., Martin, N. G., Duffy, D. L., Powell, E. E., Fawcett, J., Florin, T. H., et al. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364113 · Cited by 79
Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough
Hartl, D., Griese, M., Nicolaï, T., Zissel, G., Prell, C., Konstantopoulos, N., Gruber, R., Reinhardt, D., Schendel, D. J., & Krauss‐Etschmann, S. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.049 · Cited by 79
Liu, Q., Chen, T., Chen, G., Li, N., Wang, J., Ma, P., & Cao, X. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.024 · Cited by 79
RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects
Nakajima, K., Tanaka, Y., Nomiyama, T., Ogihara, T., Ikeda, F., Kanno, R., Iwashita, N., Sakai, K., Watada, H., Onuma, T., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.892 · Cited by 79
Th2 cells as targets for therapeutic intervention in allergic bronchial asthma
Wegmann, M. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.9.1.85 · Cited by 79
Purification and biochemical characterization of the D6 chemokine receptor
BLACKBURN, P. E., Simpson, C. V., Nibbs, R. J. B., O'HARA, M., BOOTH, R., POULOS, J., Isaacs, N. W., & Graham, G. J. (2004) · Biochemical Journal · doi:10.1042/bj20031266 · Cited by 78
L. Hebron, M. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000259 · Cited by 68
Mittal, P., Romero, R. J., Kusanovic, J. P., Edwin, S. S., Gotsch, F., Mazaki‐Tovi, S., Espinoza, J., Erez, O., Nhan‐Chang, C., Than, N. G., et al. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00620.x · Cited by 78
Nath, K. A., Kanakiriya, S., Grande, J. P., Croatt, A. J., & Katušić, Z. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64339-8 · Cited by 78
The biological basis of a comprehensive grading system for the adverse effects of cancer treatment
WILLIAMS, J., Chen, Y., Rubin, P., Finkelstein, J. N., & Okunieff, P. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00045-6 · Cited by 78
Expression of CD4 on human peripheral blood neutrophils
Biswas, P., Mantelli, B., Sica, A., Malnati, M., Panzeri, C., Saccani, A., Hasson, H., Vecchi, A. L., Saniabadi, A. R., Lusso, P., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3056 · Cited by 78
Çavuşoğlu, E., Eng, C., Chopra, V., Clark, L. T., Pinsky, D. J., & Marmur, J. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000258789.21585.76 · Cited by 78
Finley, M. J., Chen, X., Bardi, G., Davey, P., Geller, E. B., Zhang, L., Adler, M. W., & Rogers, T. J. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.021 · Cited by 77
Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2
Goyal, S., Chauhan, S. K., Zhang, Q., & Dana, R. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.125 · Cited by 77
Kollar, K., Cook, M. M., Atkinson, K., & Brooke, G. P. (2009) · International Journal of Cell Biology · doi:10.1155/2009/904682 · Cited by 76
Parmo‐Cabañas, M., Molina‐Ortiz, I., Matías-Román, S., García‐Bernal, D., Carvajal‐Vergara, X., Valle, I., Pandiella, A., Arroyo, A. G., & Teixidó, J. (2005) · The Journal of Pathology · doi:10.1002/path.1876 · Cited by 76
Tong, B., Yu, J., Wang, T., Dou, Y., Wu, X., Kong, L., Dai, Y., & Xia, Y. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.014 · Cited by 76
The genetics and biology of Irf5-mediated signaling in lupus
Kozyrev, S. V., & Alarcón-Riquelme, M. E. (2007) · Autoimmunity · doi:10.1080/08916930701510905 · Cited by 76
CXCL8 Signaling in the Tumor Microenvironment
Asokan, S., & Bandapalli, O. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_3 · Cited by 76
Calarota, S. A., Zelini, P., SILVESTRI, A. D., Chiesa, A., Comolli, G., Sarchi, E., Migotto, C., Pellegrini, C., Esposito, P. B., Minoli, L., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e318239e90c · Cited by 75
Stankovic, A., Slavić, V., Stamenkovic, B. N., Kamenov, B., Bojanovic, M., & Mitrovic, D. R. (2009) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657240 · Cited by 75
Dyer, D. P. (2020) · Immunology · doi:10.1111/imm.13200 · Cited by 75
Metadata
- Authors
- Gerard, C., & Rollins, B. J.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Gerard, Craig
- Rollins, Barrett J.
- ORCID
- Rollins, Barrett J.
- Venue
- Nature Immunology
- Published
- 2001-02
- Volume
- 2
- Issue
- 2
- Pages
- 108-115
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1602000691
- Cited by
- 1,357
- References
- 119
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 19 · 2023: 28 · 2022: 23 · 2021: 29 · 2020: 27 · 2019: 40 · 2018: 24 · 2017: 38 · 2016: 32 · 2015: 51 · 2014: 40 · 2013: 75 · 2012: 48
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- chemokines, chemokine signaling, cardiovascular disease, allergic inflammation, transplantation, neuroinflammation, cancer, HIV-associated diseases, chemokine-targeted therapy
- MeSH terms
- Animals, Arthritis, Rheumatoid, Asthma, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Humans, Multiple Sclerosis, Neoplasms, Transplantation Immunology, Transplantation, Homologous, Vascular Diseases, HIV Infections, Chemokines, Receptors, Chemokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.